AzTrials
AzTrials

Preterm ChildrenEPILANG2NCT02988570

Study on the Phenotype of Language in Preterm Born Children at 5 Years of Age

A study testing computer-evaluation of the language in people with Preterm Children, run by University Hospital, Rouen at 1 site in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

In recent years, several studies confirm that some of preterm children have language developmental disabilities, in production, in comprehension, or in written language. These language impairments lead to learning disabilities. Read more about this study

Who is it for?
Ages 5 to 6 years
Conditions the study is for
Preterm Children
What is being tested?
computer-evaluation of the language
Could I receive a placebo?
No, everyone receives an active treatment
How many people
49 participants
Where
1 siteFrance
Study dates
10 Nov 2016to 31 Mar 2017
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 5 to 6 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Children born very preterm in 2011 in the region of Haute-Normandie in France

Who cannot join

  • None

Trial locations and contacts

1 site in 1 country.

France1 site
  • Rouen University Hospital

    Rouen

Other trials in France

About this study

In recent years, several studies confirm that some of preterm children have language developmental disabilities, in production, in comprehension, or in written language. These language impairments lead to learning disabilities. There are, however, contradictions concerning the origin and nature of language dysfunctions. Some studies find lexical disorders (number of words used by the child), others preferentially phonological disorders (sounds used in the language), others also disorders of the morphosyntaxe (organization of the sentences) and fragilities that affect pragmatics (understanding situations).

The computer-evaluation of the language is carried out at five and a half year coupled with the medical and neuropsychological examinations. The language assessment lasts 30 to 45 minutes per child. It is carried out using a laptop computer that allows the submission of stimuli and recording of the child's responses. The language evaluation scale is the battery CléA (Pasquet F et al, 2014), standardized reference tool for the realization of a language evaluation. The assessment includes three tests: comprehension of words and phrases, production of words and phrases, and judgment of sentences. Each time, the child sees images and hears words or phrases. Sometimes he has to say what he sees on the computer screen.

Read more

As usual, a speech-language assessment is not carried out, routinely, at the age of 5 years in the context of the follow-up of children born very preterm.

The evaluation proposed to the child in this research will be carried out at a significant period of development, before writing. This assessment will not only assess the structure of the child's language, but also determine if there are possible difficulties in learning to read and write.

The expected benefits for the health of the children included in the trial therefore concern the detection or characterization of any developmental fragilities affecting the language. These screenings or characterizations will make it possible to advocate a speech rehabilitation if necessary.

Being tested
computer-evaluation of the language

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • computer-evaluation of the languageBehavioural

    A computer-evaluation of the language will be done for children born very preterm preterm in 2011 in the region of Haute-Normandie in France

Study groups in NCT02988570
Study groupRoleWhat they receive
children born very pretermExperimentalA computer-evaluation of the language will be done for children born very preterm preterm in 2011 in the region of Haute-Normandie in France
Receives: Behavioral: computer-evaluation of the language

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Evaluation of comprehension of words and phrases level

    A computer-based language evaluation battery (Cléa) comprising standardized test to evaluate comprehension of words and phrases will be used.

    Measured: Day 1

Secondary outcomes (2)
  1. Evaluation of production of words and phrases level

    A computer-based language evaluation battery (Cléa) comprising standardized test to evaluate production of words and phrases level will be used.

    Measured: Day 1

  2. Evaluation of judgment of sentences level

    A computer-based language evaluation battery (Cléa) comprising standardized test to evaluate judgment of sentences level will be used.

    Measured: Day 1

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted9 Dec 2016 (estimated)
  2. Study start10 Nov 2016
  3. Primary completion31 Mar 2017
  4. Study completion31 Mar 2017

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Diagnosis
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
49 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02988570
Sponsor's protocol ID
2016/338/HP
Acronym
EPILANG2
Status last verified
Apr 2018
First submitted
2 Dec 2016
Last updated
30 Apr 2018
Results posted
No
Data monitoring committee
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing computer-evaluation of the language in people with Preterm Children, run by University Hospital, Rouen at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 30 Apr 2018. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Evaluation of comprehension of words and phrases level (time frame: Day 1). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Apr 2018.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in